Búsqueda avanzada

HELENA MARUENDA CASTILLO

HELENA MARUENDA CASTILLO

HELENA MARUENDA CASTILLO

Doctor of Philosophy, STATE UNIVERSITY OF NEW YORK AT STONY BROOK

Licenciado en Química
DOCENTE ORDINARIO - PRINCIPAL
Docente a tiempo completo (DTC)
Departamento Académico de Ciencias - Sección Química

Publicaciones

Se encontraron 35 publicaciones

GALARRETA, B. C.; SIFUENTES, R. R.; CARRILLO, A. K.; SÁNCHEZ, L. A.; AMADO, M. D. R. I.; MARUENDA, H.(2008). THE USE OF NATURAL PRODUCT SCAFFOLDS AS LEADS IN THE SEARCH FOR TRYPANOTHIONE REDUCTASE INHIBITORS. BIOORGANIC & MEDICINAL CHEMISTRY. Volumen: 16. (pp. 6689 - 6695). Recuperado de: http://dx.doi.org/10.1016/j.bmc.2008.05.074
MARUENDA, H.(2002). DRUGS AGAINST TROPICAL PROTOZOAN PARASITES: TARGET SELECTION, STRUCTURAL BIOLOGY AND RATIONAL DESIGN. En Keystone Symposia. KEYSTONE.
MARUENDA, H.; CHENNA, A.; SINGER, B.(1999). Synthesis of para-benzoquinone and 1,3-bis(2-chloroethyl)-nitrosourea adducts and their incorporation into oligonucleotides. En SYNTHESIS OF P-BENZOQUINONE AND 1,3-BIS (2-CHLOROETHYL)-NITROSOUREA ADDUCTS AND THEIR OLIGONUCLEOTIDES. LYON. IARC Scientific Publications.
MARUENDA, H.; CHENNA, A.; LIEM, K.; SINGER, B.(1998). SYNTHESIS OF 1. N6-ETHANO-2-DEOSYADENOSINE, A METABOLIC PRODUCT OF 1,3-BIS(2-CHLOROETHYL)NITROSOUREA(BCNU), AND ITS INCORPORATION INTO OLIGOMERIC DNA. JOURNAL OF ORGANIC CHEMISTRY.. Volumen: 63. (pp. 4385 - 4389).
MARUENDA, H. y TOMASZ, M.(1997). ANTISENSE SEQUENCE DIRECTED CROSS-LINKING OF RNA OLIGONUCLEOTIDES BY MITOMYCIN C. Anticancer drug design. Volumen: 12. (pp. 473 - 479).
MARUENDA, H. y TOMASZ, M.(1996). ANTISENSE SEQUENCE-DIRECTED CROSS-LINKING OF DNA OLIGONUCLEOTIDES BY MITOMYCIN C. Bioconjugate chemistry. Volumen: 7. (pp. 541 - 544).
MARUENDA, H. y FRANCIS, J.(1995). DESIGN AND SYNTHESIS OF NOVEL INHIBITORS OF HIV 1 REVERSE TRANSCRIPTASE. JOURNAL OF MEDICINALCHEMISTRY.. Volumen: 38. (pp. 2145 - 2151).
MARUENDA, H.(1995). DESIGN AND SYNTHESIS OF NOVEL INHIBITORS OF HIV-1 RT. DRUGS INFORMATION JOURNAL. Volumen: 29. (pp. 2145 - 2151).